- Home
- IMMX vs PHUN Comparison
IMMX vs PHUN Comparison
Compare IMMX & PHUN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- IMMX
- PHUN
- Stock Information
- Founded
- IMMX 2014
- PHUN 2009
- Country
- IMMX United States
- PHUN United States
- Employees
- IMMX N/A
- PHUN N/A
- Industry
- IMMX Medicinal Chemicals and Botanical Products
- PHUN EDP Services
- Sector
- IMMX Health Care
- PHUN Technology
- Exchange
- IMMX Nasdaq
- PHUN Nasdaq
- Market Cap
- IMMX 65.5M
- PHUN 64.1M
- IPO Year
- IMMX 2021
- PHUN N/A
- Fundamental
- Price
- IMMX $2.19
- PHUN $2.73
- Analyst Decision
- IMMX Strong Buy
- PHUN Buy
- Analyst Count
- IMMX 1
- PHUN 2
- Target Price
- IMMX $7.00
- PHUN $7.75
- AVG Volume (30 Days)
- IMMX 250.2K
- PHUN 303.3K
- Earning Date
- IMMX 08-08-2025
- PHUN 08-08-2025
- Dividend Yield
- IMMX N/A
- PHUN N/A
- EPS Growth
- IMMX N/A
- PHUN N/A
- EPS
- IMMX N/A
- PHUN N/A
- Revenue
- IMMX N/A
- PHUN $2,400,000.00
- Revenue This Year
- IMMX N/A
- PHUN $3.01
- Revenue Next Year
- IMMX N/A
- PHUN $50.72
- P/E Ratio
- IMMX N/A
- PHUN N/A
- Revenue Growth
- IMMX N/A
- PHUN N/A
- 52 Week Low
- IMMX $1.26
- PHUN $2.22
- 52 Week High
- IMMX $3.20
- PHUN $14.60
- Technical
- Relative Strength Index (RSI)
- IMMX 39.38
- PHUN 46.34
- Support Level
- IMMX $2.11
- PHUN $2.50
- Resistance Level
- IMMX $2.39
- PHUN $2.76
- Average True Range (ATR)
- IMMX 0.21
- PHUN 0.12
- MACD
- IMMX -0.03
- PHUN 0.01
- Stochastic Oscillator
- IMMX 9.52
- PHUN 61.04
About IMMX Immix Biopharma Inc.
Immix Biopharma Inc is engaged in the discovery and development of novel cell therapies for hematologic malignancies (blood cancers) and other indications. It is a clinical-stage biopharmaceutical company developing a novel class of Tissue-Specific Therapeutics TM in oncology and inflammation. Its TME Normalization Technology allows drug candidates to circulate in the bloodstream, exit through tumor blood vessels and simultaneously attack all components of the TME. Its product candidates include CAR-T NXC-201 for autoimmune diseases, and IMX-110 for treatment of soft tissue sarcoma.
About PHUN Phunware Inc.
Phunware Inc is a software company. It is a cloud platform for mobile that provides companies with the products, solutions, and data and services necessary to engage, manage and monetize its mobile application audiences. It derives maximum revenue from United States. The company has two reportable segments: Software subscriptions and services; and Advertising. It derives maximum revenue from Software subscriptions and services.